|3rd September 2020||Matthew Strobeck||350||Open or private purchase||$155.64||$54,474.00|
|3rd September 2020||Matthew Strobeck||50||Open or private purchase||$155.60||$7,779.85|
|2nd September 2020||Matthew Strobeck||300||Open or private purchase||$167.74||$50,320.50|
|2nd September 2020||Matthew Strobeck||7,000||Open or private purchase||$166.60||$1,166,190.20|
|26th August 2020||Jack W Schuler||365,241||Open or private purchase||$4.25||$1,552,274.25|
|1st July 2020||Jack W Schuler||2,285,715||Open or private purchase||$3.50||$8,000,002.50|
|26th June 2020||Jack W Schuler||2,424,242||Open or private purchase||$1.65||$3,999,999.30|
|26th June 2020||Jack W Schuler||5,151,517||Open or private purchase||$1.65||$8,500,003.05|
|18th June 2020||Romney Humphries||3,000||Exercise of derivative||$5.93||$17,790.00|
|18th June 2020||Romney Humphries||3,000||Open or private sale||$12.00||$36,000.00|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 9/10.
Accelerate Diagnostics, Inc. is an in vitro diagnostics company. The company was founded on May 26, 1982 and is headquartered in Tucson, AZ. It focuses on developing and commercializing innovative instrumentation.